These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30738642)

  • 21. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
    Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR
    Thompson D; Morrice N; Grant L; Le Sommer S; Lees EK; Mody N; Wilson HM; Delibegovic M
    Clin Sci (Lond); 2017 Oct; 131(20):2489-2501. PubMed ID: 28899902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice.
    Hollie NI; Konaniah ES; Goodin C; Hui DY
    Atherosclerosis; 2014 Jun; 234(2):377-80. PubMed ID: 24747111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice.
    Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM
    J Lipid Res; 2011 May; 52(5):885-96. PubMed ID: 21343632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
    Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
    Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.
    Krishnamurthy K; Glaser S; Alpini GD; Cardounel AJ; Liu Z; Ilangovan G
    Cardiovasc Res; 2016 Jul; 111(1):74-83. PubMed ID: 27131506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr
    Al-Sharea A; Murphy AJ; Huggins LA; Hu Y; Goldberg IJ; Nagareddy PR
    Atherosclerosis; 2018 Apr; 271():166-176. PubMed ID: 29518749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.
    Choi JH; Jeon HJ; Park JG; Sonn SK; Lee MR; Lee MN; You HJ; Kim GY; Kim JH; Lee MH; Kwon OS; Nam KH; Kim HC; Jeong TS; Lee WS; Oh GT
    Atherosclerosis; 2010 Sep; 212(1):146-52. PubMed ID: 20684827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearing the Clutter: Antiatherosclerotic activity of Eucalyptus camaldulensis crude extract.
    -Ain QU; Ahmed A; Nisa Iqbal MU; Hashmi IA; Khan NI; Khan TA
    Pak J Pharm Sci; 2021 Nov; 34(6):2205-2211. PubMed ID: 35034882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.
    VanderLaan PA; Reardon CA; Thisted RA; Getz GS
    J Lipid Res; 2009 Mar; 50(3):376-385. PubMed ID: 18957695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
    Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet.
    Lai P; Du JR; Zhang MX; Kuang X; Li YJ; Chen YS; He Y
    J Ethnopharmacol; 2011 Oct; 137(3):1061-6. PubMed ID: 21718773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.